FDA Grants Breakthrough Device Designation to nQ Medical for Parkinson’s Disease Management Platform

Related Articles:

• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Parkinson's Disease News - Editor's Picks (Archive 2016.09) October 15, 2016 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed ‘The Terrorist Inside My Husband’s Brain’: Robin Williams’ Widow Details His Disease – Live ScienceLive Science'The Terrorist Inside My Husband's Brain': Robin Williams' Widow Details His DiseaseLive ScienceBut Robin Williams was not diagnosed with Lewy body disease…
• FDA Grants Breakthrough Device Designation for nQ Medical’s neuroQWERTY February 11, 2020 The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to nQ Medical’s neuroQUERTY software, which is designed to monitor brain health and Parkinson’s disease progression. Breakthrough device status is given to medical devices that have the potential to be an effective treatment or diagnostic tool for life-threatening or irreversibly debilitating diseases. The status speeds the review and assessment…
• FDA Names Spectramax Light Therapy ‘Breakthrough Device’ for Parkinson’s May 4, 2020 The United States Food and Drug Administration (FDA) has granted breakthrough device designation to PhotoPharmics‘s light-based, at-home device as an add-on therapy for Parkinson’s disease. This designation is given to medical devices with the potential to offer more effective treatment for life-threatening or debilitating diseases. It grants the company access to experts at the FDA during development, and paves the way…
• Parkinson's Disease News - Editor's Picks (Archive 2016.10) November 28, 2016 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed LA Tech’s “Rock Steady Boxing” helping people fight Parkinson’s Disease – Knoe.comKnoe.comLA Tech's 'Rock Steady Boxing' helping people fight Parkinson's DiseaseKnoe.comNeal was an ENT specialist until he got hit by the disease just a few years ago.…
• Monthly Research Review – July 2021 July 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during July 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Parkinson's Disease News - Editor's Picks (Archive 2016.07) September 30, 2016 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed Pedaling for Parkinson’sThat is what it’s like living with Parkinson’s disease. Parkinson’s disease is a chronic, neurodegenerative disorder in which the loss of cells in various parts of the brain leaves people less able to control their…
• Monthly research review – March 2021 March 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during March 2021. The post is divided into ten parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Monthly Research Review – October 2021 October 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2021. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Parkinson's Disease News - Editor's Picks (Archive 2016.11) March 17, 2017 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed Neurons Paralyze Us During REM SleepIt will also be most useful in the study of Parkinson’s disease, since these pathologies are related. This work was published on December 12, 2016 on the website of the journal Brain.…
• August 3, 2019 - Parkinson FIT Weekend Update August 3, 2019 This Week’s Highlights: Sustainable Exercise for Parkinson's; inhalable levodopa; Virtual Reality for PD Therapy; When grilled cheese attacks; inspiring people with PD; alpha-synuclein & spontaneous origami; PD Exercise news; Dyskinesia predictors; prescription drugs that might decrease or increase PD risk; dopamine and acetylcholine; basal tears vs. skin tests for biomarkers; blue light therapy glasses; PD constipation; and more
• APDA’s Newly Funded 2023 Research Awardees September 13, 2022 On September 8, 2022, APDA announced 27 new research grants for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease (PD) to develop new treatments and eventually, a cure. We are honored to support our researcher’s work. We awarded $2.35 million to support cutting-edge PD research for the 2022-2023 year – a 25% increase in…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• The Bluerockers have started July 15, 2021 # # # # On the 8th June, BlueRock Therapeutics put out a press release announcing that the first participant in their Phase I clinical trial of cell transplantation for Parkinson’s had been dosed (Click here to read the press release). The initiation of this clinical trial by the company is a major step forward for them and for the…
• Monthly Research Review – October 2022 October 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during October 2022. The post is divided into 10 parts based on the type of research: Top 5 pieces of Parkinson’s news Articles of general interest Basic biology…
• Word for Wednesday: Resilience August 3, 2022 “Resilience is not what happens to you. It’s how you react to, respond to, and recover from what happens to you.” Jeffrey Gitomer “He who has a why to live for can bear almost any how.” Friedrich Nietzsche “The greater the force of your compassion, the greater your resilience in confronting hardships.” Dalai Lama Defining Resilience: The Cambridge dictionary gives…
• Monthly Research Review: January 2022 January 31, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during January 2022. The post is divided into 10 parts based on the type of research: Top 6 pieces of Parkinson’s news Articles of general interest Basic biology…
• Pushing for Progress: American Parkinson Disease Association Funding To Accelerate Scientists’ Pursuit for Answers August 31, 2021 Pushing for Progress: American Parkinson Disease Association Funding To Accelerate Scientists’ Pursuit for Answers From biomarker development to the use of sono-optogenetics, $1.85 million in innovative research to be funded for 2021– 2022 year NEW YORK, NY, September 1, 2021 – The American Parkinson Disease Association (APDA) has just awarded $1.85 million to support cutting-edge Parkinson’s disease (PD) research for…
• Prevail lands on a Lilly pad December 15, 2020 # # # # 2020 has been a dreadful year for most of the world – burdened by the outbreak and consequences of COVID-19. Despite this, there has been a steady stream of biotech acquisitions related to Parkinson’s which have helped to keep morale high in the PD research community. In October alone, we saw the Portuguese pharmaceutical company Bial…
• New and innovative Parkinson’s disease research being funded by APDA September 7, 2021 NEW, INNOVATIVE PARKINSON’S DISEASE RESEARCH BEING FUNDED BY APDA On September 1, 2021, APDA announced our research grantees for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease in an effort to develop new treatments and eventually, a cure, and we are honored to support their work. This year APDA awarded $1.85 million…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…